´ëÇѺ¸Á¶»ý½ÄÇÐȸ Á¦42Â÷ Çмú´ëȸ : 2024-02-25
±³À°ÀÏÀÚ : 2024-02-25
±³À°Àå¼Ò : ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º
±³À°ÁÖÁ¦ : ´ëÇѺ¸Á¶»ý½ÄÇÐȸ Á¦42Â÷ Çмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑ»êºÎÀΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѺ¸Á¶»ý½ÄÇÐȸ
´ã´çÀÚ : À̺¸¶ó
¿¬¶ôó : 031-738-0968
À̸ÞÀÏ : 2019kosar@gmail.com
±³À°Á¾·ù : »êºÎÀΰú
Âü¼®¿¹»óÀÎ : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : °æ±âµµ
±³À°½Ã°£ : 6 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 60,000¿ø
ºñ°í ¿ÀÇÁ¶óÀÎ Á¤È¸¿ø, ºñȸ¿ø 6¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 02¿ù 25ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º 08:20~08:55 µî·Ï ()
±âŸ 02¿ù 25ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º 08:55~09:00 °³È¸»ç ÀÌÅÃÈÄ(´ëÇѺ¸Á¶»ý½ÄÇÐȸ ȸÀå)
±³À°½Ã°£ 02¿ù 25ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º 09:00~09:20 Good practice recommendations on recurrent implantation failure ÀÌÀçÈÆ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 02¿ù 25ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º 09:20~09:40 Fertility-sparing treatment of patients with endometrial carcinoma (ESGO/ESHRE/ESGE Guideline) ÀÌÁö¼±(°æÁ×ÀÇ´ë)
±³À°½Ã°£ 02¿ù 25ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º 09:40~10:00 Good practice recommendations on add-ons in reproductive medicine ÀÌ´Ù¿ë(¼¿ïÀÇ´ë)
Åä·Ð 02¿ù 25ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º 10:00~10:10 Discussion ()
ÈÞ½Ä 02¿ù 25ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º 10:10~10:30 Coffee Break ()
±³À°½Ã°£ 02¿ù 25ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º 10:30~10:50 Why do euploid blastocysts fail to implant? ·ù»ó¿ì(°¨ÀÚ¿Í ´«»ç¶÷ ¿©¼ºÀÇ¿ø)
±³À°½Ã°£ 02¿ù 25ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º 10:50~11:10 Clinical outcomes of mosaic embryo transfer ±è¼¼Á¤(Â÷ÀÇ°úÇдë)
±³À°½Ã°£ 02¿ù 25ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º 11:10~11:30 Sclerotherapy for ovarian endometrioma in infertile women : when and how? Á¶Á¤Çö(»ç¶û¾ÆÀÌ¿©¼ºÀÇ¿ø)
Åä·Ð 02¿ù 25ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º 11:30~11:40 Discussion ()
±³À°½Ã°£ 02¿ù 25ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º 11:40~12:10 Fertility outcomes of oil-based contrast media during hysterosalpingography ÀåÇýÁø(¾ÆÁÖÀÇ´ë)
ÈÞ½Ä 02¿ù 25ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º 12:10~13:00 Lunch ()
±³À°½Ã°£ 02¿ù 25ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º 13:00~13:15 ³ÀÓ¿ì¿ïÁõ»ó´ã¼¾ÅÍ ¼Ò°³ Ã־ȳª(±¹¸³Áß¾ÓÀÇ·á¿ø/Áß¾Ó³ÀÓ¿ì¿ïÁõ »ó´ã¼¾ÅÍÀå)
±³À°½Ã°£ 02¿ù 25ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º 13:15~13:45 ³ÀÓÄ¡·á ´Ü°èº° ½É¸®Áö¿ø À̼ÒÈñ(±¹¸³Áß¾ÓÀÇ·á¿ø Á¤½Å°Ç°ÀÇÇаú/Áß¾Ó³ÀÓ¿ì¿ïÁõ »ó´ãºÎ¼¾ÅÍÀå)
±³À°½Ã°£ 02¿ù 25ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º 13:45~14:15 À¯»êºÎºÎ¸¦ À§ÇÑ ½É¸®Áö¿ø À̽ÂÀç(°æºÏÀÇ´ë Á¤½Å°Ç°ÀÇÇаú/´ë±¸±Ç¿ª³ÀÓ¿ì¿ïÁõ »ó´ãºÎ¼¾ÅÍÀå)
Åä·Ð 02¿ù 25ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º 14:15~14:40 Discussion ()
ÈÞ½Ä 02¿ù 25ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º 14:40~15:00 Coffee Break ()
±³À°½Ã°£ 02¿ù 25ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º 15:00~15:20 Up-to-date approaches to improve endometrial receptivity ¹®°æ¿ë(¾ÆÀÌ¿À¶ó ¿©¼ºÀÇ¿ø)
±³À°½Ã°£ 02¿ù 25ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º 15:20~15:40 Update on Non-Invasive Preimplatation Genetic Testing (niPGT) ¹ÚÀ±Á¤(°í·ÁÀÇ´ë)
Åä·Ð 02¿ù 25ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º 15:40~15:50 Discussion ()
±³À°½Ã°£ 02¿ù 25ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º 15:50~16:10 Culture conditions for IVM of oocytes and embryo development ¾öÁøÈñ(°³²Â÷º´¿ø)
±³À°½Ã°£ 02¿ù 25ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º 16:10~16:30 Gametes and embryo selection for successful IVF pregnancy ÀÌÁÖÈñ(º£½ºÆ®¿Àºê¹Ì ¿©¼ºÀÇ¿ø)
Åä·Ð 02¿ù 25ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º 16:30~16:40 Discussion ()
±âŸ 02¿ù 25ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º 16:40~16:50 Æóȸ»ç ()